Helen Baxendale

9.9k total citations
45 papers, 1.4k citations indexed

About

Helen Baxendale is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Helen Baxendale has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 15 papers in Immunology and 13 papers in Infectious Diseases. Recurrent topics in Helen Baxendale's work include Pneumonia and Respiratory Infections (14 papers), SARS-CoV-2 and COVID-19 Research (11 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Helen Baxendale is often cited by papers focused on Pneumonia and Respiratory Infections (14 papers), SARS-CoV-2 and COVID-19 Research (11 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Helen Baxendale collaborates with scholars based in United Kingdom, Germany and Netherlands. Helen Baxendale's co-authors include Jeremy Brown, Jonathan Cohen, David Goldblatt, Corné de Vogel, Robert Wilson, Ricardo J. José, Catherine Hyams, José Yuste, Richard Rosenquist and Eva Hellqvist and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Blood.

In The Last Decade

Helen Baxendale

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Baxendale United Kingdom	19	643	540	224	217	207	45	1.4k
Sue Blackwell United States	17	1.1k 1.7×	156 0.3×	314 1.4×	91 0.4×	179 0.9×	56	1.6k
R.J. O’Reilly United States	25	1.0k 1.6×	513 0.9×	355 1.6×	92 0.4×	110 0.5×	63	2.3k
J. S. Hill Gaston United Kingdom	27	917 1.4×	303 0.6×	312 1.4×	220 1.0×	58 0.3×	53	1.7k
Sergio Arce United States	19	1.2k 1.9×	189 0.3×	279 1.2×	39 0.2×	67 0.3×	37	1.9k
Susan L. Heatley Australia	18	752 1.2×	312 0.6×	371 1.7×	34 0.2×	111 0.5×	51	1.7k
Leen Moens Belgium	18	751 1.2×	310 0.6×	192 0.9×	46 0.2×	72 0.3×	41	1.1k
Fran Hakim United States	16	1.0k 1.6×	673 1.2×	213 1.0×	23 0.1×	81 0.4×	34	2.0k
Mieke C. Brouwer Netherlands	21	1.0k 1.6×	243 0.5×	406 1.8×	30 0.1×	190 0.9×	50	1.8k
Maria C. Faber‐Krol Netherlands	14	827 1.3×	90 0.2×	215 1.0×	110 0.5×	107 0.5×	15	1.2k
Paul Scholl United States	19	1.9k 3.0×	286 0.5×	293 1.3×	52 0.2×	51 0.2×	38	2.4k

Countries citing papers authored by Helen Baxendale

Since Specialization

Citations

This map shows the geographic impact of Helen Baxendale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Baxendale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Baxendale more than expected).

Fields of papers citing papers by Helen Baxendale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Baxendale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Baxendale. The network helps show where Helen Baxendale may publish in the future.

Co-authorship network of co-authors of Helen Baxendale

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Baxendale. A scholar is included among the top collaborators of Helen Baxendale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Baxendale. Helen Baxendale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nadesalingam, Angalee, Andrew Chan, Peter Smith, et al.. (2023). Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies. SHILAP Revista de lepidopterología. 2(2). 100091–100091. 3 indexed citations

Sadée, Christoph, Stephen Harding, Jernej Ule, et al.. (2022). SARS-CoV-2 Spike Protein Binding of Glycated Serum Albumin—Its Potential Role in the Pathogenesis of the COVID-19 Clinical Syndromes and Bias towards Individuals with Pre-Diabetes/Type 2 Diabetes and Metabolic Diseases. International Journal of Molecular Sciences. 23(8). 4126–4126. 11 indexed citations

Ali, Youssif M., Nicholas J. Lynch, Priyanka Khatri, et al.. (2022). Secondary Complement Deficiency Impairs Anti-Microbial Immunity to Klebsiella pneumoniae and Staphylococcus aureus During Severe Acute COVID-19. Frontiers in Immunology. 13. 841759–841759. 7 indexed citations

Cantoni, Diego, Martin Mayora Neto, Nazia Thakur, et al.. (2022). Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients. Communications Biology. 5(1). 409–409. 8 indexed citations

Nadesalingam, Angalee, Diego Cantoni, Minna Paloniemi, et al.. (2022). Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies. The Lancet Microbe. 4(2). e58–e59. 9 indexed citations

Baxendale, Helen, David A. Wells, George Carnell, et al.. (2021). Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19. SHILAP Revista de lepidopterología. 7(3). 199–210. 3 indexed citations

Albecka, Anna, Dean Clift, Marina Vaysburd, et al.. (2021). A functional assay for serum detection of antibodies against SARS‐CoV‐2 nucleoprotein. The EMBO Journal. 40(17). e108588–e108588. 18 indexed citations

Edgar, David, Alex Richter, Aarnoud Huissoon, et al.. (2018). Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland. Journal of Clinical Immunology. 38(2). 204–213. 24 indexed citations

Hou, Tie Zheng, Nisha Verma, Jennifer Wanders, et al.. (2017). Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. Blood. 129(11). 1458–1468. 71 indexed citations

10.

Wilson, Robert, Jonathan Cohen, Mark Reglinski, et al.. (2017). Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens. PLoS Pathogens. 13(1). e1006137–e1006137. 67 indexed citations

11.

Dziadzio, Magdalena, Jennifer A. Harvey, Roy G. Smith, et al.. (2017). Comparison of 23-Valent Pneumococcal IgG ELISA with Multiplex 13-Valent Serotype-Specific Antibody Assay as Diagnostic Tools in Subjects with Suspected Antibody Deficiency. 2017(2). 1–6. 3 indexed citations

12.

Condliffe, Alison M., et al.. (2015). Familial Hepatopulmonary Syndrome in Common Variable Immunodeficiency. Journal of Clinical Immunology. 35(3). 302–304. 5 indexed citations

13.

Cohen, Jonathan, Suneeta Chimalapati, Corné de Vogel, et al.. (2012). Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation. Vaccine. 30(30). 4453–4459. 17 indexed citations

14.

Wu, Bryan, Victoria Martin, Ulrich Sack, et al.. (2011). Vaccination‐induced changes in human B‐cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell. 10(6). 922–930. 100 indexed citations

15.

Baxendale, Helen, Sheila M. Keating, Marina Johnson, et al.. (2010). The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly. Vaccine. 28(30). 4763–4770. 33 indexed citations

16.

Baxendale, Helen, Marina Johnson, Sheila M. Keating, et al.. (2010). Circulating pneumococcal specific plasma and memory B cells in the elderly two years after pneumococcal conjugate versus polysaccharide vaccination. Vaccine. 28(42). 6915–6922. 16 indexed citations

17.

Smith, Claire M., Carla Lo Passo, Jan Kolberg, et al.. (2009). Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae. European Journal of Immunology. 39(6). 1527–1535. 7 indexed citations

18.

Yuste, José, Lennart Truedsson, Göran Jönsson, et al.. (2008). Impaired Opsonization with C3b and Phagocytosis ofStreptococcus pneumoniaein Sera from Subjects with Defects in the Classical Complement Pathway. Infection and Immunity. 76(8). 3761–3770. 86 indexed citations

19.

Baxendale, Helen & David Goldblatt. (2006). Correlation of Molecular Characteristics, Isotype, and In Vitro Functional Activity of Human Antipneumococcal Monoclonal Antibodies. Infection and Immunity. 74(2). 1025–1031. 11 indexed citations

20.

Baxendale, Helen, Zadie Davis, Harry N White, et al.. (2000). Immunogenetic analysis of the immune response to pneumococcal polysaccharide. European Journal of Immunology. 30(4). 1214–1223. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact